Back
BioCryst Pharmaceuticals Stock Predictions
Buy
59
BCRX
BioCryst Pharmaceuticals
Last Price:
6.29
Seasonality Move:
28.24%
7 Day Trial
ALL ACCESS PASS
$
7
BioCryst Pharmaceuticals Stock Forecast
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 37.6% based on the past 30 years of stock performance.
- BioCryst Pharmaceuticals has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
-
Is BioCryst Pharmaceuticals Stock Undervalued?
The current BioCryst Pharmaceuticals [BCRX] share price is $6.28. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal. - BCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will BioCryst Pharmaceuticals Stock Go Up Next Year?
- Over the next 52 weeks, BioCryst Pharmaceuticals has on average historically risen by 37.6% based on the past 30 years of stock performance.
BioCryst Pharmaceuticals Stock Rating
Buy
59
BioCryst Pharmaceuticals (BCRX)
is a Buy
Is BioCryst Pharmaceuticals overpriced?
- BioCryst Pharmaceuticals has risen higher in 13 of those 30 years over the subsequent 52-week period, corresponding to a historical accuracy of 43.33%
BioCryst Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biocryst.com
52-Week Data
52-Week High:
8.96
52-Week Low:
4.03
Prediction Charts
Market Cap:
1.3B
Price in USD:
6.28
Volume:
4.2M
Beta:
1.67
Technical Analysis
SMA50:
4.96
SMA100:
5.38
SMA200:
5.85
52-Wk Change:
-25.86%
Stock Predictions
-
Is BioCryst Pharmaceuticals stock public?
Yes, BioCryst Pharmaceuticals is a publicly traded company. -
What is the BioCryst Pharmaceuticals stock quote today?
The BioCryst Pharmaceuticals stock price is 6.28 USD today. -
How to buy BioCryst Pharmaceuticals stock online?
You can buy BioCryst Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Apr-30 | 4.20 | 4.13 | 4.26 | 4.11 |
| May-1 | 4.18 | 4.57 | 4.77 | 4.15 |
| May-2 | 4.61 | 4.48 | 4.68 | 4.41 |
| May-3 | 4.59 | 4.45 | 4.67 | 4.42 |
| May-6 | 5.00 | 5.27 | 5.47 | 4.75 |
| May-7 | 5.39 | 5.26 | 5.70 | 5.23 |
| May-8 | 5.18 | 5.10 | 5.42 | 5.04 |
| May-9 | 5.14 | 5.34 | 5.35 | 5.06 |
| May-10 | 5.38 | 5.32 | 5.78 | 5.23 |
| May-13 | 5.47 | 5.63 | 5.69 | 5.34 |
| May-14 | 5.72 | 5.36 | 6.00 | 5.35 |
| May-15 | 5.93 | 6.36 | 6.56 | 5.90 |
| May-16 | 6.40 | 6.47 | 6.59 | 6.15 |
| May-17 | 6.43 | 6.28 | 6.56 | 6.22 |
BioCryst Pharmaceuticals Earnings
BioCryst Pharmaceuticals Earnings Report: Per Share BioCryst Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
BioCryst Pharmaceuticals Forecast Revenue Growth
BioCryst Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for BioCryst Pharmaceuticals and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and an increase next year of $0.26 per share.
* BioCryst Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.